{
"info": {
"nct_id": "NCT05345860",
"official_title": "Adopting the MRD Strategy to Optimize Post-operation Adjuvant Therapies for Early Stage Breast Cancer, a Prospective Cohort Study",
"inclusion_criteria": "* Subjects aged ≥18 years (inclusive).\n* Histologically confirmed, perioperative invasive breast cancer that is resectable without metastasis(stage I-III).\n* No anti-breast cancer systematic therapy received, and planning to receive surgery and systemic therapy.\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.\n* With Adequate Organ Function:\n\n a. Bone marrow function: Hemoglobin ≥ 10 g/dL; Absolute leucocyte count ≥ 4×10^9/L; Absolute neutrophil count ≥ 1.5×10^9/L; Platelets ≥ 100 × 10^9/L; b. Liver function (based on the normal values specified by study site): Serum total bilirubin ≤ 1.5 × the upper limit of normal (ULN); Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 × ULN; c. Renal function (based on the normal values specified by study site): Serum creatinine ≤ 1.5 × ULN.\n* The patients voluntarily signed an informed consent form.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Known to have other aggressive malignant tumor that is progressing or requires systemic treatment in the past 5 years (does not exclude subjects with skin basal cell carcinoma, skin squamous cell carcinoma, breast ductal carcinoma in situ or cervical cancer in situ that has received curative treatment).\n* Have a clear history of neurological or mental disorders, including epilepsy or dementia, etc.; have a history of psychotropic drug abuse or drug abuse.\n* Known history of allergy to the drug components in MRD strategy; history of immunodeficiency, or history of organ transplantation.\n* There are other concomitant diseases that seriously threaten the patient's safety or affect the patient's completion of the study, such as serious infection, liver disease, cardiovascular disease, kidney disease, respiratory disease or uncontrolled diabetes or dyslipidemia.\n* Female patients during pregnancy or lactation.\n* The investigator determines that subjects are not appropriate to participate in the study due to other factors.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Subjects aged ≥18 years (inclusive).",
"criterions": [
{
"exact_snippets": "aged ≥18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Histologically confirmed, perioperative invasive breast cancer that is resectable without metastasis(stage I-III).",
"criterions": [
{
"exact_snippets": "Histologically confirmed",
"criterion": "histological confirmation",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": true
}
]
},
{
"exact_snippets": "perioperative invasive breast cancer",
"criterion": "breast cancer type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "perioperative invasive"
}
]
},
{
"exact_snippets": "resectable",
"criterion": "resectability",
"requirements": [
{
"requirement_type": "resectability",
"expected_value": true
}
]
},
{
"exact_snippets": "without metastasis",
"criterion": "metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "stage I-III",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"I",
"II",
"III"
]
}
]
}
]
},
{
"line": "* No anti-breast cancer systematic therapy received, and planning to receive surgery and systemic therapy.",
"criterions": [
{
"exact_snippets": "No anti-breast cancer systematic therapy received",
"criterion": "anti-breast cancer systematic therapy",
"requirements": [
{
"requirement_type": "received",
"expected_value": false
}
]
},
{
"exact_snippets": "planning to receive surgery",
"criterion": "surgery",
"requirements": [
{
"requirement_type": "planning to receive",
"expected_value": true
}
]
},
{
"exact_snippets": "planning to receive ... systemic therapy",
"criterion": "systemic therapy",
"requirements": [
{
"requirement_type": "planning to receive",
"expected_value": true
}
]
}
]
},
{
"line": "* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0-2.",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* With Adequate Organ Function:",
"criterions": [
{
"exact_snippets": "Adequate Organ Function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "a. Bone marrow function: Hemoglobin ≥ 10 g/dL; Absolute leucocyte count ≥ 4×10^9/L; Absolute neutrophil count ≥ 1.5×10^9/L; Platelets ≥ 100 × 10^9/L; b. Liver function (based on the normal values specified by study site): Serum total bilirubin ≤ 1.5 × the upper limit of normal (ULN); Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 × ULN; c. Renal function (based on the normal values specified by study site): Serum creatinine ≤ 1.5 × ULN.",
"criterions": [
{
"exact_snippets": "Bone marrow function: Hemoglobin ≥ 10 g/dL",
"criterion": "hemoglobin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 10,
"unit": "g/dL"
}
}
]
},
{
"exact_snippets": "Bone marrow function: ... Absolute leucocyte count ≥ 4×10^9/L",
"criterion": "absolute leucocyte count",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 4,
"unit": "×10^9/L"
}
}
]
},
{
"exact_snippets": "Bone marrow function: ... Absolute neutrophil count ≥ 1.5×10^9/L",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 1.5,
"unit": "×10^9/L"
}
}
]
},
{
"exact_snippets": "Bone marrow function: ... Platelets ≥ 100 × 10^9/L",
"criterion": "platelets",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 100,
"unit": "×10^9/L"
}
}
]
},
{
"exact_snippets": "Liver function ... Serum total bilirubin ≤ 1.5 × the upper limit of normal (ULN)",
"criterion": "serum total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "× ULN"
}
}
]
},
{
"exact_snippets": "Liver function ... Alanine aminotransferase (ALT) ... ≤ 2.5 × ULN",
"criterion": "alanine aminotransferase (ALT)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "× ULN"
}
}
]
},
{
"exact_snippets": "Liver function ... aspartate aminotransferase (AST) ≤ 2.5 × ULN",
"criterion": "aspartate aminotransferase (AST)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "× ULN"
}
}
]
},
{
"exact_snippets": "Renal function ... Serum creatinine ≤ 1.5 × ULN",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 1.5,
"unit": "× ULN"
}
}
]
}
]
},
{
"line": "* The patients voluntarily signed an informed consent form.",
"criterions": [
{
"exact_snippets": "patients voluntarily signed an informed consent form",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Known to have other aggressive malignant tumor that is progressing or requires systemic treatment in the past 5 years (does not exclude subjects with skin basal cell carcinoma, skin squamous cell carcinoma, breast ductal carcinoma in situ or cervical cancer in situ that has received curative treatment).",
"criterions": [
{
"exact_snippets": "other aggressive malignant tumor that is progressing",
"criterion": "other aggressive malignant tumor",
"requirements": [
{
"requirement_type": "progression",
"expected_value": true
}
]
},
{
"exact_snippets": "other aggressive malignant tumor ... requires systemic treatment in the past 5 years",
"criterion": "other aggressive malignant tumor",
"requirements": [
{
"requirement_type": "systemic treatment",
"expected_value": true
},
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Have a clear history of neurological or mental disorders, including epilepsy or dementia, etc.; have a history of psychotropic drug abuse or drug abuse.",
"criterions": [
{
"exact_snippets": "clear history of neurological or mental disorders, including epilepsy or dementia",
"criterion": "neurological or mental disorders",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
},
{
"exact_snippets": "history of psychotropic drug abuse",
"criterion": "psychotropic drug abuse",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
},
{
"exact_snippets": "history of ... drug abuse",
"criterion": "drug abuse",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* Known history of allergy to the drug components in MRD strategy; history of immunodeficiency, or history of organ transplantation.",
"criterions": [
{
"exact_snippets": "Known history of allergy to the drug components in MRD strategy",
"criterion": "allergy to drug components",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "history of immunodeficiency",
"criterion": "immunodeficiency",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "history of organ transplantation",
"criterion": "organ transplantation",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
},
{
"line": "* There are other concomitant diseases that seriously threaten the patient's safety or affect the patient's completion of the study, such as serious infection, liver disease, cardiovascular disease, kidney disease, respiratory disease or uncontrolled diabetes or dyslipidemia.",
"criterions": [
{
"exact_snippets": "serious infection",
"criterion": "serious infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "liver disease",
"criterion": "liver disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "cardiovascular disease",
"criterion": "cardiovascular disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "kidney disease",
"criterion": "kidney disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "respiratory disease",
"criterion": "respiratory disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled diabetes",
"criterion": "uncontrolled diabetes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "dyslipidemia",
"criterion": "dyslipidemia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Female patients during pregnancy or lactation.",
"criterions": [
{
"exact_snippets": "Female patients during pregnancy",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Female patients ... lactation",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* The investigator determines that subjects are not appropriate to participate in the study due to other factors.",
"criterions": [
{
"exact_snippets": "subjects are not appropriate to participate in the study due to other factors",
"criterion": "appropriateness to participate",
"requirements": [
{
"requirement_type": "determination",
"expected_value": "not appropriate"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}